JPRN-jRCT2080220827未知3 期
A phase III study of ATL-962 in subject with obesity
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1.Inpatient/Outpatient status during the run-in period: Outpatient
- •2.The subject who is capable of providing consent to participate in this study, with ability to read and understand the informed consent form and other written information, etc.
排除标准
- •1.The subject with serious cardiac disease, cerebrovascular disorder, or serious pancreatic or hematological disease, etc.
- •2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator, etc.
研究者
相似试验
未知
3 期
Phase III Study of ATL-962 in Obese PatientsObesityJPRN-jRCT2080221428Takeda Pharmaceutical Company Limited
已完成
1 期
Phase I Study of RTA 402 in Obese AdultsJPRN-jRCT2080224778Kyowa Kirin Co., Ltd.18
未知
3 期
A phase 3 confrimatory study of ATL-962ObesityJPRN-jRCT2080220634Takeda Pharmaceutical Company Limited210
未知
2 期
A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemiaObesityJPRN-jRCT2080222949Shionogi & Co., Ltd.
已完成
2 期
Safety and Efficacy Study of S-309309 in Obese AdultsObesityNCT05925114Shionogi365